Pages that link to "Q70106779"
Jump to navigation
Jump to search
The following pages link to Reexamination of the efficacy of vaccination against mousepox (Q70106779):
Displaying 9 items.
- Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy. (Q33567970) (← links)
- Epithelial immunization induces polyfunctional CD8+ T cells and optimal mousepox protection (Q34059189) (← links)
- Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance (Q36082819) (← links)
- Deletion of the vaccinia virus growth factor gene reduces virus virulence (Q36876074) (← links)
- Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses (Q36884500) (← links)
- Identification of the promoter of the mouse obese gene (Q37629731) (← links)
- Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. (Q37629901) (← links)
- Vaccines produced by conventional means to control major infectious diseases of man and animals (Q38612861) (← links)
- Acute inflammatory response to cowpox virus infection of the chorioallantoic membrane of the chick embryo (Q45880311) (← links)